Viewing Study NCT00542204


Ignite Creation Date: 2025-12-24 @ 9:15 PM
Ignite Modification Date: 2026-02-17 @ 6:50 PM
Study NCT ID: NCT00542204
Status: COMPLETED
Last Update Posted: 2015-04-28
First Post: 2007-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Use of Online Personalized Health Record System to Promote Self-Management of Diabetes
Sponsor: Palo Alto Medical Foundation
Organization:

Study Overview

Official Title: Patient-Centered Online Disease Management Using a Personal Health Record System
Status: COMPLETED
Status Verified Date: 2015-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: EMPOWER-D
Brief Summary: Diabetes is a major, growing, and costly chronic disease in the U.S., and implementation of recommended diabetes care remains poor, not merely suboptimal, and varied for a sizable proportion of Americans with diabetes. To further reduce the treatment and adherence gaps in diabetes care, the researchers propose to evaluate a Customized, Continuous Care Management (CCCM) program that actively supports a partnership between the patient and his/her multidisciplinary care management (CM) team using an online disease management (ODM) system, which is integrated with a comprehensive electronic health record (EHR) system that includes a personal health record and secure patient-clinician messaging capabilities. The CCCM program builds upon CM strategies proven effective in past studies and creates an ODM system that is built upon and fully integrated with a leading, commercially available EHR product - providing a blueprint for instituting customized, continuous care management for many different chronic conditions in a range of ambulatory care settings.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: